Company Profile
Day One Biopharmaceuticals Stock Price, News & Analysis
- Ticker:
- DAWN
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Day One Biopharmaceuticals is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
21.53 USD (+0.19%)
Close
Last updated: April 22, 2026 at 00:00
2.22B USD
Market cap
Why the stock is moving
DAWN is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Day One Biopharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Day One Biopharmaceuticals is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Day One Biopharmaceuticals follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Day One Biopharmaceuticals sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
Day One to Acquire Mersana Therapeutics to Advance Mission to Bring New Medicines to People of All Ages with Life-Threatening Diseases
Source: Day One Biopharmaceuticals
- 03
Day One to Participate in the Piper Sandler 37th Annual Healthcare Conference
Source: Day One Biopharmaceuticals
- 04
- 05
Day One to Present at the 44th Annual J.P. Morgan Healthcare Conference
Source: Day One Biopharmaceuticals
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Day One Biopharmaceuticals (DAWN)?
Day One Biopharmaceuticals (DAWN) most recently closed at 21.53 USD, a +0.19% move versus the previous session.
What is the market cap of Day One Biopharmaceuticals (DAWN)?
Day One Biopharmaceuticals currently has a market capitalization of 2.22B USD on BioPharmSignal.
What does Day One Biopharmaceuticals do?
Day One Biopharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is DAWN stock listed?
Day One Biopharmaceuticals (DAWN) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Day One Biopharmaceuticals is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Biopharmaceuticals?
Day One Biopharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Day One Biopharmaceuticals targeting with Biopharmaceuticals?
Day One Biopharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.